SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

CytomX Therapeutics, Inc. backtest

10 trend-following strategies were compared on the full daily history of CytomX Therapeutics, Inc.. 10 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is 볼린저 밴드 돌파 (CAGR 3.8%, MDD -76.4%).

Data 2015-10-08 ~ 2026-09-30daily bars 2,760 (11.0 years)Costs 0.5%Venue XNASMonthly snapshot 2026-09-30

Results by strategy

10 of 10 beat buy and hold (CAGR -13.3%, drawdown -98.7%).

Sharpe leader (same as main): Supertrend — CAGR 12.8%, MDD -83.1%, Sharpe 0.47, 36% exposure.

Return/drawdown alternative: 볼린저 밴드 돌파 — CAGR is 26.1%p higher than buy and hold, while drawdown improves by 15.6%p (CAGR 3.8%, MDD -76.4%, exposure 16%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=11, mult=3.2
12.8%-83.1%0.470.153.8x4836%
Donchian 채널 돌파
entryN=47, exitN=68
3.6%-91.1%0.360.041.5x2049%
Keltner 채널 돌파
emaPeriod=21, atrPeriod=22, mult=1.4
5.9%-77.3%0.340.081.9x7422%
EMA 크로스오버
fast=30, slow=71
-0.4%-90.4%0.30-0.001.0x3436%
볼린저 밴드 돌파
n=12, k=2.3
3.8%-76.4%0.300.051.5x8416%
ROC 모멘텀
n=116, threshold=0.01
-1.2%-86.4%0.29-0.010.9x7440%
SMA 크로스오버
fast=6, slow=149
-1.5%-89.3%0.29-0.020.8x3635%
MACD
fast=19, slow=26, signal=23
-0.7%-93.6%0.29-0.010.9x10052%
ADX / DI 방향성
period=12, threshold=27
2.6%-89.9%0.270.031.3x7019%
Parabolic SAR
step=0.02, maxStep=0.04
-2.1%-94.7%0.27-0.020.8x11041%
Buy and hold-13.3%-98.7%0.28-0.130.2x1100%
0.1 1x 2016 2018 2020 2022 2024 2026 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -49% -74% -99% 2016 2018 2020 2022 2024 2026 Buy and holdSupertrend
Supertrend maximum drawdown -83.1% (2020-05-12 → 2025-04-16), recovered after 2,075 days.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 120 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next